ArticleArthritis research & therapy2021

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry.

Lucie Nekvindová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.